Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. N-(7-chloro-n-quinuclidin-3-yl)benzo(b)thiophene-2-carboxamide
1. Evp-6124
2. 550999-75-2
3. Evp 6124
4. Evp6124
5. N-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-7-chloro-1-benzothiophene-2-carboxamide
6. Chembl2151572
7. 5fi5376a0x
8. Mt4666
9. Mt-4666
10. Benzo(b)thiophene-2-carboxamide, N-(3r)-1-azabicyclo(2.2.2)oct-3-yl-7-chloro-
11. (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide
12. 7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide
13. Unii-5fi5376a0x
14. Encenicline [usan:inn]
15. Frm-6124
16. I33
17. Encenicline [inn]
18. Encenicline (usan/inn)
19. Encenicline [usan]
20. Encenicline [who-dd]
21. Schembl744767
22. Gtpl6926
23. (r)-7-chloro-n-(quinuclidin-3-yl)benzo(b)thiophene-2-carboxamide
24. Dtxsid701025836
25. Ex-a3984
26. Bdbm50393255
27. Mfcd23381267
28. Zinc95579362
29. Cs-0933
30. Db11726
31. Ncgc00378871-01
32. Hy-15430
33. D10626
34. A913801
35. Q19904062
36. (r)-7-chloro-n-(quinuclidine-3-yl)benzo[b]thiophene-2-carboxamide
37. N-((3r)-1-azabicyclo(2.2.2)oct-3-yl)-7-chloro-1-benzothiophene-2-carboxamide
38. N-(3r)-1-azabicyclo[2.2.2]oct-3-yl-7-chlorobenzo[b]thiophene-2-carboxamide
39. 1275596-71-8
| Molecular Weight | 320.8 g/mol |
|---|---|
| Molecular Formula | C16H17ClN2OS |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 320.0750120 g/mol |
| Monoisotopic Mass | 320.0750120 g/mol |
| Topological Polar Surface Area | 60.6 Ų |
| Heavy Atom Count | 21 |
| Formal Charge | 0 |
| Complexity | 413 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Encenicline, a selective, orally active, alpha 7 Nicotinic Acetylcholine Receptor agonist (alpha 7 NAchR agonist). Encenicline may have a similar mechanism of action to GTS-21. Auditory sensory gating, a biological measurement of the ability to suppress the evoked response to the second of two auditory stimuli, is diminished in people with schizophrenia. Deficits in sensory gating are associated with attentional impairment, and may contribute to cognitive symptoms and perceptual disturbances. This inhibitory process, which involves the alpha(7) nicotinic receptor mediated release of gamma-aminobutyric acid (GABA) by hippocampal interneurons, represents a potential new target for therapeutic intervention in schizophrenia.
ABOUT THIS PAGE
64
PharmaCompass offers a list of EVP-6124 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right EVP-6124 manufacturer or EVP-6124 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred EVP-6124 manufacturer or EVP-6124 supplier.
PharmaCompass also assists you with knowing the EVP-6124 API Price utilized in the formulation of products. EVP-6124 API Price is not always fixed or binding as the EVP-6124 Price is obtained through a variety of data sources. The EVP-6124 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A EVP 6124 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of EVP 6124, including repackagers and relabelers. The FDA regulates EVP 6124 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. EVP 6124 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A EVP 6124 supplier is an individual or a company that provides EVP 6124 active pharmaceutical ingredient (API) or EVP 6124 finished formulations upon request. The EVP 6124 suppliers may include EVP 6124 API manufacturers, exporters, distributors and traders.
EVP 6124 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of EVP 6124 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right EVP 6124 GMP manufacturer or EVP 6124 GMP API supplier for your needs.
A EVP 6124 CoA (Certificate of Analysis) is a formal document that attests to EVP 6124's compliance with EVP 6124 specifications and serves as a tool for batch-level quality control.
EVP 6124 CoA mostly includes findings from lab analyses of a specific batch. For each EVP 6124 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
EVP 6124 may be tested according to a variety of international standards, such as European Pharmacopoeia (EVP 6124 EP), EVP 6124 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (EVP 6124 USP).
